Pure Global

LDL-cholesterol Quantitative Testing Drug - Vietnam Registration 220003444/PCBB-HCM

Access comprehensive regulatory information for LDL-cholesterol Quantitative Testing Drug in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loแบกi B medical device is registered under number 220003444/PCBB-HCM and manufactured by Roche Diagnostics GmbH.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
220003444/PCBB-HCM
Registration Details
Vietnam MOH Registration: 220003444/PCBB-HCM
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

LDL-cholesterol Quantitative Testing Drug
VN: Thuแป‘c thแปญ xรฉt nghiแป‡m ฤ‘แป‹nh lฦฐแปฃng LDL-cholesterol
Risk Class TTBYT Loแบกi B

Registration Details

220003444/PCBB-HCM

000.00.19.H29-221026-0014

LDLC3

07005768190

Company Information

Technical Details

In vitro testing used to quantify LDL-cholesterol in human serum and plasma on the Roche/Hitachi cobas c. systems

Dates and Status

Oct 28, 2022